Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 EUR | +5.26% | -1.64% | -20.00% |
2023 | MedNation AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Eifelhöhen-Klinik AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 15.39 | 9.475 | 6.035 | 11.65 | 11.35 | 10.2 |
Enterprise Value (EV) 1 | 26.95 | 21.36 | 46.94 | 48.39 | 61.88 | 60.8 |
P/E ratio | -128 x | -8.49 x | -7.69 x | -8.21 x | -2.58 x | -5.37 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.32 x | 0.19 x | 0.12 x | 0.32 x | 0.31 x | 0.27 x |
EV / Revenue | 0.56 x | 0.42 x | 0.94 x | 1.33 x | 1.69 x | 1.62 x |
EV / EBITDA | 12.7 x | 9.84 x | 13.1 x | 33.4 x | 57 x | 23.9 x |
EV / FCF | -5.34 x | 91.7 x | 9.36 x | 12.5 x | 45.4 x | 43.3 x |
FCF Yield | -18.7% | 1.09% | 10.7% | 7.97% | 2.2% | 2.31% |
Price to Book | 0.89 x | 0.6 x | 0.38 x | 0.81 x | 1.13 x | 1.11 x |
Nbr of stocks (in thousands) | 3,017 | 3,017 | 3,017 | 3,017 | 3,017 | 3,017 |
Reference price 2 | 5.102 | 3.140 | 2.000 | 3.860 | 3.760 | 3.380 |
Announcement Date | 30/04/18 | 01/05/19 | 30/05/20 | 30/04/21 | 29/04/22 | 28/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 48.2 | 50.76 | 49.91 | 36.37 | 36.69 | 37.55 |
EBITDA 1 | 2.122 | 2.17 | 3.576 | 1.449 | 1.086 | 2.548 |
EBIT 1 | 0.1728 | 0.008225 | 1.409 | -0.4725 | -0.7857 | 1.286 |
Operating Margin | 0.36% | 0.02% | 2.82% | -1.3% | -2.14% | 3.42% |
Earnings before Tax (EBT) 1 | 0.006523 | -0.5974 | -0.075 | -1.193 | -4.102 | -1.724 |
Net income 1 | -0.1144 | -1.111 | -0.7733 | -1.418 | -4.4 | -1.888 |
Net margin | -0.24% | -2.19% | -1.55% | -3.9% | -11.99% | -5.03% |
EPS 2 | -0.0400 | -0.3700 | -0.2600 | -0.4700 | -1.460 | -0.6300 |
Free Cash Flow 1 | -5.048 | 0.2328 | 5.014 | 3.858 | 1.362 | 1.404 |
FCF margin | -10.47% | 0.46% | 10.05% | 10.61% | 3.71% | 3.74% |
FCF Conversion (EBITDA) | - | 10.73% | 140.22% | 266.32% | 125.4% | 55.11% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 30/04/18 | 01/05/19 | 30/05/20 | 30/04/21 | 29/04/22 | 28/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 11.6 | 11.9 | 40.9 | 36.7 | 50.5 | 50.6 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 5.447 x | 5.477 x | 11.44 x | 25.36 x | 46.52 x | 19.86 x |
Free Cash Flow 1 | -5.05 | 0.23 | 5.01 | 3.86 | 1.36 | 1.4 |
ROE (net income / shareholders' equity) | -0.47% | -6.13% | -4.14% | -8.31% | -32.8% | -17.9% |
ROA (Net income/ Total Assets) | 0.18% | 0.01% | 1.33% | -0.4% | -0.66% | 1.04% |
Assets 1 | -62.72 | -12,624 | -58.07 | 352.2 | 670.4 | -181.8 |
Book Value Per Share 2 | 5.710 | 5.220 | 5.300 | 4.750 | 3.320 | 3.050 |
Cash Flow per Share 2 | 4.550 | 3.380 | 2.480 | 2.340 | 2.080 | 1.700 |
Capex 1 | 7.28 | 0.6 | 1.29 | 0.43 | 0.96 | 0.29 |
Capex / Sales | 15.1% | 1.19% | 2.58% | 1.18% | 2.61% | 0.77% |
Announcement Date | 30/04/18 | 01/05/19 | 30/05/20 | 30/04/21 | 29/04/22 | 28/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-20.00% | 3.67M | |
-18.46% | 16.57B | |
+4.50% | 12.43B | |
+4.98% | 11.69B | |
+4.44% | 10.24B | |
-3.10% | 7.59B | |
+20.21% | 7.15B | |
+6.45% | 6.8B | |
+50.68% | 4.65B | |
-5.12% | 4.22B |
- Stock Market
- Equities
- EIF Stock
- Financials MedNation AG